Regeneron Pharmaceuticals, Inc.
HealthcareNASDAQ:REGN · NASDAQ Global Select
+$3.57 today
Vol 0.37M · Avg 0.87M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+18.46%
Period High
$810.09
Period Low
$506.09
Latest
$614.80
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elevance Health Inc.
NYSE:ELV
$87.37B
Cigna Corporation
NYSE:CI
$78.83B
argenx SE
NASDAQ:ARGX
$55.64B
Cencora, Inc.
NYSE:COR
$54.88B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.14B
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
$37.94B
Zoetis Inc.
NYSE:ZTS
$33.63B
United Therapeutics Corporation
NASDAQ:UTHR
$22.96B
Incyte Corporation
NASDAQ:INCY
$21.81B
Genmab A/S
NASDAQ:GMAB
$15.37B
What is the latest REGN filing?
The latest filing shown is 13F-HR dated May 8, 2026.
How many recent filings does REGN have?
Intrinsic Alpha currently shows 20 recent filings for REGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.